Francois M. Cuenot

Saint-denis-de-palin, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France.

COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France.

Journal: JAMA network open
Published: December 04, 2025

The renin-angiotensin system in healthy human platelets: expressed but inactive.

The renin-angiotensin system in healthy human platelets: expressed but inactive.

Journal: Platelets
Published: August 18, 2025

Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.

Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.

Journal: JAMA
Published: August 26, 2024

StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models.

StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models.

Journal: Cell
Published: May 21, 2024

Site-directed conjugation of single-stranded DNA to affinity proteins: quantifying the importance of conjugation strategy.

Site-directed conjugation of single-stranded DNA to affinity proteins: quantifying the importance of conjugation strategy.

Journal: Chemical science
Published: March 19, 2024

Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case-Control Study Based on the French National Health Data System.

Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case-Control Study Based on the French National Health Data System.

Journal: Open forum infectious diseases
Published: April 26, 2023

Pharmacoepidemiology and public decision.

Pharmacoepidemiology and public decision.

Journal: Therapie
Published: November 24, 2022

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines.

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines.

Journal: Therapie
Published: November 24, 2022

Impact of coronavirus disease 2019 on contraception use in France.

Impact of coronavirus disease 2019 on contraception use in France.

Journal: Therapie
Published: November 22, 2022

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France.

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France.

Journal: The Lancet regional health. Europe
Published: July 05, 2022

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France.

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France.

Journal: Contraception
Published: September 20, 2021

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people.

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people.

Journal: The Lancet regional health. Europe
Published: July 26, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026